SecBot SecBot
EFFECT ·Filed Jul 13, 2026

PLSM

Pulsenmore Ltd.
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago SEC9999999995-26-002262
IPO/offering going effective
Actionable Insight • Neutral

The EFFECT notice makes the F-1 registration live, enabling Armistice Capital to resell up to 3.125M shares. Monitor for selling pressure from Armistice, which could weigh on PLSM's stock. The company's cash position and burn rate remain the key fundamental drivers — watch for any subsequent capital raise announcement.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PLSM ▼ -40.33% at T+60d
NEUTRAL call -40.33% · α vs SPY -44.33% · entry $3.62 → $2.16
Entry = T+0 close
Jul 13, 2026
via day close
T+1d
+7.46%
call +7.46% · α +7.10%
$3.89
settled 3mo ago
T+5d
+5.52%
call +5.52% · α +6.31%
$3.82
settled 3mo ago
T+20d
-9.94%
call -9.94% · α -13.13%
$3.26
settled 3mo ago
T+60d
-40.33%
call -40.33% · α -44.33%
$2.16
settled 20d ago

Price Chart

Loading chart...

Executive Summary

Pulsenmore's F-1 registration statement has been declared effective by the SEC, enabling the resale of 3,125,000 ordinary shares by Armistice Capital Master Fund Ltd. The company will not receive any proceeds from the resale, but the effectiveness removes a key procedural barrier, allowing the selling shareholder to begin selling shares immediately. This creates a potential overhang of ~3.1M shares (approximately 12% of shares outstanding based on the $25M market cap), though the company could receive up to ~$7.5M if the underlying warrants are exercised for cash.

Key Facts

  • F-1 registration declared effective, covering 3,125,000 ordinary shares held by Armistice Capital Master Fund Ltd.
  • The company will not receive any proceeds from the resale of shares by Armistice.
  • The company could receive up to ~$7.5M if Armistice exercises its warrants for cash.
  • The F-1 was filed 11 days ago on July 2, 2026.

Financial Impact

No new capital raised by the company; potential $7.5M from warrant exercise is contingent and uncertain.

dilutionshare count

Risk Factors

  • Selling pressure from Armistice Capital's resale of 3.125M shares could depress PLSM's stock price.
  • The company may still need additional capital beyond the potential $7.5M warrant exercise proceeds.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

Report based on filing metadata.

13 reports for PLSM
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+60▲ +58.09%Jun 25, 2026
Filters
Rows
Reports for PLSM — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
6-K
NEUTRAL ★ 3/10
$1.90awaiting T+20—$1.76 (−7.47%)
Oct 8, 2026
17d ago
SC 13G
NEUTRAL ★ 3/10
$1.85awaiting T+20—$1.76 (−4.97%)
Sep 17, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$2.42 $1.81▼ −25.21%▼ −26.41%$1.76 (−27.36%)
Sep 8, 2026
6w ago
6-K
BULLISH ★ 6/10
$2.46 $2.16▼ −12.20%▼ −13.91%$1.76 (−28.54%)
Sep 2, 2026
7w ago
EFFECT
BEARISH ★ 5/10
$2.55 $2.22▲ +12.94%▲ +12.86%$1.76 (+31.06%)
Aug 31, 2026
8w ago
6-K
MIXED ★ 5/10
$2.62 $2.19▼ −16.41%▼ −16.22%$1.76 (−32.90%)
Aug 19, 2026
9w ago
6-K
NEUTRAL ★ 3/10
$3.01 $2.42▼ −19.60%▼ −18.76%$1.76 (−41.59%)
Aug 17, 2026
10w ago
6-K
NEUTRAL ★ 4/10
$2.89 $2.41▼ −16.61%▼ −14.63%$1.76 (−39.17%)
Jul 13, 2026
15w ago
6-K
NEUTRAL ★ 4/10
$3.62 $3.26▼ −9.94%▼ −13.13%$1.76 (−51.44%)
Jul 13, 2026
15w ago
EFFECT
NEUTRAL ★ 4/10
$3.62 $3.26▼ −9.94%▼ −13.13%$1.76 (−51.44%)
Showing 10 of 13

US Market Status

Market Open — Closes in 2h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 13, 2026